Recently published studies and meta-analyses indicated that VEGF is a promising prognostic biomarker for papillary thyroid cancer (11), oral tongue squamous cell carcinoma (12), cervical cancer (13, 14), colorectal cancer (15), and other cancers (16–27). Here, VEGFA is linked to cancer.